NIDDK Funding Opportunity

U01 Research Project Cooperative Agreement

Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (U01)

This Funding Opportunity Announcement (FOA) invites applications for the Accelerating Medicines Partnership (AMP) in Type 2 Diabetes (T2D-GENES) consortium. The AMP T2D-GENES will build on and expand the previous work of the T2D GENES consortium. The aim of the consortium is to characterize the genetic variations in human genomic regions that have been putatively associated with type 2 diabetes (T2D) and conduct follow-up functional studies of particular genetic variants. The data coordinating center for the consortium is being solicited via the companion FOA.

Full AnnouncementRFA-DK-14-003
Notice(s) for this Opportunity
Open Date6/18/2014
Letter of Intent Due Date
June 18, 2014
Application Due Date
July 18, 2014, by 5:00 PM local time of applicant organization.
NIDDK Program ContactBeena Akolkar, Ph.D.

Print Page

Click outside of the light box to close the box.